July 5, 2023 7:40am

Electronic trading, speculation and volatility still lurk; is a summer slowdown coming, or will it just keep stay on the roller-coaster?

My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today, not yesterday with a bit for tomorrow.

Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!  Never leave an investor uninformed! 

8:00 a.m. edition

Remember that overnight and pre-open actions in futures don't necessarily translate into actual trading in the coming day’s session. My interpretation of the morning’s numbers is written to be informative; it’s built on what will happen behind the headlines today, not tomorrow or yesterday

 

Dow futures are DOWN -0.44% or (-152 points), S&P futures are DOWN -0.45% or (-20 points) and NASDAQ futures are DOWN -0.51% or (-79 points) early in the pre-open – so far

U.S. stock futures fell Wednesday,

European markets were lower

Asia-Pacific markets fell.

 

Henry’omics:

We need to more than consider the economic environment - rising rates and inflation to comprehend the micro re “our” universe of cell and gene therapy companies …

Monday closed up with the Dow pushing +10.87 (+0.03%), the S&P +5.21 (+0.12%) and the Nasdaq +28.85 (+0.21%).

Monday, all three (3) major U.S. indexes defied recession fears and uncertainty from the U.S. banking crisis to end 1H/23 on a positive note, with the Nasdaq rallying 31.7% to its biggest 1H/23 increase in four (4) decades.

Economic Data Docket: May factory orders data; economists are anticipating a rise of 0.6%, which would be greater than the 0.4% increase the previous month.

·         June’s Fed meeting minutes at 2 p.m. ET, which could shed some light on the path for interest rate hikes going forward.

·         New York Fed President John Williams is expected to speak at 4 p.m. ET at the 2023 Annual Meeting of the Central Bank Research Association (CEBRA) in New York City.

 

Ebb and flow:

Q3: 1 Vacation Day (short session, 1 Holiday

Q2/23 -

·         June -1 Holiday, 9 negative and 11 positive closes

·         May – 10 negative and 12 positive closes

·         April ended - 1 holiday, 8 positive close and 11 negative closes

Q1/23 –-

·         March – ended with 10 positive and 13 negative closes

·         February – 1 holiday, 2 vacation, 7 negative and 8 positive closes

·         January – 2 holidays, 11 positive and 9 negative closes

 

Companies in my headlights – It’s your decision; I provide ideas and context: INDICATIONS

Pre-open Indication: I consider a pause but, will check in periodically

 

The BOTTOM LINE:

I follow the dictum, quoting Churchill that “short words are best, and the old words when short are best of all, as I try to keep it simple and short!

WHO is a work this week, I’m half in watching periodically. No rain after the past few days … catch some rays.

Earnings are about to be ready for release – questions are …RUNWAYS on track for further growth?

"Time in the market is better than timing the market" is investing wisdom that's maintained its relevance for a reason.” <Nasdaq>

I hate to be so negative or contrarian but, this is a NO spin zone and truth is its product; I can always be WRONG but, I am mostly EARLY!

More bad news, approximately 700 workers were laid off from Massachusetts life sciences companies in the Q2/23.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions securities referred to in this publication.